MBCP+™, Biomatlante’s synthetic bone graft matrix, has been confirmed as the adapted matrix of choice for tissue engineering and was selected for use in a 5-year trial in the treatment of long bone nonunions.
The ORTHOUNION randomized clinical trial will compare a combination of MBCP+ and expanded bone marrow mesenchymal stem cells (MSCs) to autograft in the treatment of long bone nonunions. ORTHOUNION is funded with €6MM from the EU’s Horizon 2020 research and innovation program.
This follows 2016 results of the REBORNE study, which demonstrated a high rate of clinical success from a combination of MBCP+ and MSCs, particularly in the treatment of long bone nonunions. MBCP+ will also be used in a trial focusing on use prior to dental surgery.
Sources: Biomatlante; ec.europa.eu; ORTHOWORLD Inc.
MBCP+™, Biomatlante's synthetic bone graft matrix, has been confirmed as the adapted matrix of choice for tissue engineering and was selected for use in a 5-year trial in the treatment of long bone nonunions.
The ORTHOUNION randomized clinical trial will compare a combination of MBCP+ and expanded bone marrow mesenchymal stem cells (MSCs) to...
MBCP+™, Biomatlante’s synthetic bone graft matrix, has been confirmed as the adapted matrix of choice for tissue engineering and was selected for use in a 5-year trial in the treatment of long bone nonunions.
The ORTHOUNION randomized clinical trial will compare a combination of MBCP+ and expanded bone marrow mesenchymal stem cells (MSCs) to autograft in the treatment of long bone nonunions. ORTHOUNION is funded with €6MM from the EU’s Horizon 2020 research and innovation program.
This follows 2016 results of the REBORNE study, which demonstrated a high rate of clinical success from a combination of MBCP+ and MSCs, particularly in the treatment of long bone nonunions. MBCP+ will also be used in a trial focusing on use prior to dental surgery.
Sources: Biomatlante; ec.europa.eu; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
